300009 安科生物
按盤價 
9.830 +1.100 (+12.600%)
9.830 +1.100 (+12.600%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 11.115 | 24.395 | 23.461 | 7.350 | 13.143 |
| 總資產報酬率 ROA (%) | 8.496 | 18.403 | 17.746 | 5.761 | 10.666 |
| 投入資產回報率 ROIC (%) | 10.811 | 23.685 | 22.864 | 7.233 | 12.950 | 邊際利潤分析 |
| 銷售毛利率 (%) | 78.246 | 78.353 | 78.406 | 80.062 | 78.778 |
| 營業利潤率 (%) | 37.957 | 32.242 | 36.121 | 13.715 | 24.923 |
| 息稅前利潤/營業總收入 (%) | 37.795 | 31.968 | 35.668 | 13.281 | 23.767 |
| 淨利潤/營業總收入 (%) | 32.627 | 29.960 | 31.645 | 9.378 | 20.367 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 92.802 | 101.666 | 92.447 | 207.494 | 99.197 |
| 價值變動淨收益/利潤總額(%) | 1.721 | -0.560 | 4.929 | 8.622 | -0.180 |
| 營業外收支淨額/利潤總額(%) | -0.199 | -0.440 | -0.977 | -0.786 | -1.899 | 償債能力分析 |
| 流動比率 (X) | 2.922 | 2.745 | 2.827 | 3.066 | 3.473 |
| 速動比率 (X) | 2.507 | 2.468 | 2.516 | 2.777 | 3.145 |
| 資產負債率 (%) | 18.461 | 20.571 | 20.089 | 20.864 | 0.164 |
| 帶息債務/全部投入資本 (%) | -1.291 | -1.701 | -2.329 | -2.970 | -2.341 |
| 股東權益/帶息債務 (%) | -7,537.287 | -5,718.036 | -4,160.325 | -3,302.521 | -4,218.060 |
| 股東權益/負債合計 (%) | 419.319 | 366.977 | 375.201 | 364.013 | 492.068 |
| 利息保障倍數 (X) | -435.906 | -240.501 | -347.433 | -40.631 | -34.396 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 76.253 | 59.994 | 64.782 | 69.678 | 86.620 |
| 存貨周轉天數 (天) | 172.741 | 129.323 | 140.078 | 140.021 | 139.336 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
